Critical ReviewAnti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
Under a Creative Commons license
open access
Keywords
High mobility group box-1 (HMGB1)
Monoclonal antibody (mAb)
DAMP
Neuroinflammation
Stroke
TBI
Epilepsy
Neuropathic pain
Cited by (0)
Peer review under responsibility of Japanese Pharmacological Society.
© 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.